Kinloch Capital, LLC Abb Vie Inc. Transaction History

Kinloch Capital, LLC

$211 Million
Q2 2025

A detailed history of Kinloch Capital, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Kinloch Capital, LLC holds 24,158 shares of ABBV stock, worth $5.38 Million. This represents 2.12% of its overall portfolio holdings.

Number of Shares

24,158

Previous 23,325 3.57%

Holding current value

$5.38 Million

Previous $4.89 Million 8.25%

% of portfolio

2.12%

Previous 2.39%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$170.16 - $206.27 $141,743 - $171,822	833 Added 3.57%	24,158 $4.48 Million
Q1 2025 May 14, 2025	BUY	$169.2 - $216.66 $808,606 - $1.04 Million	4,779 Added 25.77%	23,325 $4.89 Million
Q3 2024 Nov 14, 2024	SELL	$163.84 - $199.33 $72,908 - $88,701	-445 Reduced 2.34%	18,546 $3.66 Million
Q2 2024 Aug 14, 2024	SELL	$154.79 - $180.76 $11,454 - $13,376	-74 Reduced 0.39%	18,991 $3.26 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $201,373 - $229,446	1,260 Added 7.08%	19,065 $3.47 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $66,048 - $74,385	-480 Reduced 2.63%	17,805 $2.76 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $39,008 - $45,157	-292 Reduced 1.57%	18,285 $2.73 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $39,885 - $49,634	-301 Reduced 1.59%	18,577 $2.5 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $1.96 Million - $2.26 Million	-13,550 Reduced 41.78%	18,878 $3.01 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $126,415 - $151,605	914 Added 2.9%	32,428 $5.24 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $28,049 - $32,171	209 Added 0.67%	31,514 $4.23 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $155,923 - $198,229	1,133 Added 3.76%	31,305 $4.8 Million
Q1 2022 May 12, 2022	BUY	$131.98 - $163.75 $157,848 - $195,845	1,196 Added 4.13%	30,172 $4.89 Million
Q4 2021 Jan 20, 2022	BUY	$107.43 - $135.93 $774,462 - $979,919	7,209 Added 33.12%	28,976 $3.92 Million
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $233,654 - $265,232	2,196 Added 11.22%	21,767 $2.35 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $40,716 - $45,360	387 Added 2.02%	19,571 $2.2 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $129,307 - $142,351	1,264 Added 7.05%	19,184 $2.08 Million
Q4 2020 Jan 21, 2021	BUY	$80.49 - $108.67 $1.44 Million - $1.95 Million	17,920 New	17,920 $1.92 Million

Others Institutions Holding ABBV

# of Institutions

4,290

Shares Held

1.3B

Call Options Held

16.1M

Put Options Held

10.9M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $394B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kinloch Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kinloch Capital, LLC with notifications on news.

Account

Kinloch Capital, LLC Abb Vie Inc. Transaction History